Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.
作者信息
Niciu Mark J, Luckenbaugh David A, Ionescu Dawn F, Mathews Daniel C, Richards Erica M, Zarate Carlos A
机构信息
National Institutes of Health/National Institute of Mental Health, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, Bethesda, Maryland.
出版信息
Biol Psychiatry. 2013 Nov 15;74(10):e23-4. doi: 10.1016/j.biopsych.2013.01.038. Epub 2013 May 28.
Abstract
摘要
相似文献
1
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.亚麻醉剂量的氯胺酮不会在三个独立的难治性重度抑郁症样本中诱发情感转换。
Biol Psychiatry. 2013 Nov 15;74(10):e23-4. doi: 10.1016/j.biopsych.2013.01.038. Epub 2013 May 28.
2
Reply to: Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.回复：亚麻醉剂量氯胺酮不会在三个独立的难治性重度抑郁症样本中引发情感转换。
Biol Psychiatry. 2013 Nov 15;74(10):e25. doi: 10.1016/j.biopsych.2013.03.019. Epub 2013 May 28.
3
Induction of prolonged mania during ketamine therapy for reflex sympathetic dystrophy.氯胺酮治疗反射性交感神经营养不良期间诱发的持续性躁狂。
Biol Psychiatry. 2011 Aug 15;70(4):e13-4. doi: 10.1016/j.biopsych.2011.02.030. Epub 2011 May 6.
4
A Case of Possible Iatrogenic Ketamine-Induced Mania in a Patient Being Treated for Postoperative Pain.
Psychosomatics. 2016 Sep-Oct;57(5):543-6. doi: 10.1016/j.psym.2016.06.003. Epub 2016 Jun 16.
5
Subanesthetic ketamine infusions for suicide ideation in patients with bipolar and unipolar treatment refractory depression.亚麻醉剂量氯胺酮输注用于双相和单相治疗难治性抑郁症患者的自杀观念。
Psychiatry Res. 2021 Feb;296:113645. doi: 10.1016/j.psychres.2020.113645. Epub 2020 Dec 16.
6
Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain.慢性疼痛患者氯胺酮镇痛的群体药代动力学-药效学模型研究。
Eur J Pain. 2011 Mar;15(3):258-67. doi: 10.1016/j.ejpain.2010.06.016. Epub 2010 Jul 17.
7
Ketamine-Induced Mania During Treatment for Complex Regional Pain Syndrome.
Pain Med. 2017 Oct 1;18(10):2040-2041. doi: 10.1093/pm/pnx061.
8
Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.重复和递增术前亚麻醉剂量氯胺酮用于肿瘤切除术后疼痛控制的患者：一项随机、安慰剂对照、双盲试验。
Clin Ther. 2011 Jul;33(7):863-73. doi: 10.1016/j.clinthera.2011.05.094. Epub 2011 Jul 1.
9
Pain relief is associated with improvement in motor function in complex regional pain syndrome type 1: secondary analysis of a placebo-controlled study on the effects of ketamine.疼痛缓解与 1 型复杂性区域疼痛综合征运动功能的改善相关：氯胺酮安慰剂对照研究的二次分析。
J Pain. 2013 Nov;14(11):1514-21. doi: 10.1016/j.jpain.2013.07.013. Epub 2013 Sep 24.
10
A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients.一种用于复杂性区域疼痛综合征患者的新型复方镇痛乳膏（氯胺酮、己酮可可碱、可乐定、二甲基亚砜）
Pain Pract. 2016 Jan;16(1):E14-20. doi: 10.1111/papr.12404. Epub 2015 Nov 7.
引用本文的文献
1
Effects of ketamine on the severity of depression and anxiety following postoperative mechanical ventilation: a single-blind randomized clinical trial in Iran.氯胺酮对术后机械通气后抑郁和焦虑严重程度的影响：伊朗的一项单盲随机临床试验
Acute Crit Care. 2024 May;39(2):243-250. doi: 10.4266/acc.2023.01186. Epub 2024 May 24.
2
Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects.氯胺酮作为重度抑郁症和创伤后应激障碍的治疗药物：潜在的药用和有害影响。
Ibrain. 2023 Feb 20;9(1):90-101. doi: 10.1002/ibra.12094. eCollection 2023 Spring.
3
Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder.在重度抑郁症和双相情感障碍患者的难治性精神病性抑郁症中，在标准治疗基础上加用氯胺酮的中枢神经系统相关安全性和耐受性。
Front Neurosci. 2023 Jul 11;17:1214972. doi: 10.3389/fnins.2023.1214972. eCollection 2023.
4
Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?别孕烯醇酮：解释压力对抽动加剧影响的缺失环节？
J Neuroendocrinol. 2022 Feb;34(2):e13022. doi: 10.1111/jne.13022. Epub 2021 Aug 22.
5
Ketamine for Bipolar Depression: A Systematic Review.双相抑郁的氯胺酮治疗：系统评价。
Int J Neuropsychopharmacol. 2021 Jul 23;24(7):535-541. doi: 10.1093/ijnp/pyab023.
6
Ketamine in Bipolar Disorder: A Review.氯胺酮治疗双相情感障碍：综述
Neuropsychiatr Dis Treat. 2020 Nov 12;16:2707-2717. doi: 10.2147/NDT.S282208. eCollection 2020.
7
Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review.与口服低剂量氯胺酮治疗难治性双相 I 型抑郁症患者相关的情感转换。病例报告及文献综述。
Front Psychiatry. 2020 Jun 3;11:516. doi: 10.3389/fpsyt.2020.00516. eCollection 2020.
8
The influence of ketamine on drug discovery in depression.氯胺酮对抑郁症药物研发的影响。
Drug Discov Today. 2019 Oct;24(10):2033-2043. doi: 10.1016/j.drudis.2019.07.007. Epub 2019 Aug 2.
9
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.快速作用抗抑郁药氯胺酮及其代谢物和其他候选药物：历史概述和未来展望。
Psychiatry Clin Neurosci. 2019 Oct;73(10):613-627. doi: 10.1111/pcn.12902. Epub 2019 Jul 11.
10
Glutamatergic Modulators in Depression.谷氨酸能调节剂在抑郁症中的作用。
Harv Rev Psychiatry. 2018 Nov/Dec;26(6):307-319. doi: 10.1097/HRP.0000000000000183.
本文引用的文献
1
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study.在为期 4 周的双盲、安慰剂对照研究中，与添加利鲁唑相比，单次静脉输注氯胺酮对抑郁症状改善的过程：结果。
Neuropsychopharmacology. 2012 May;37(6):1526-33. doi: 10.1038/npp.2011.338. Epub 2012 Feb 1.
2
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.双相抑郁中氯胺酮抗抑郁疗效的复制：一项随机对照附加试验。
Biol Psychiatry. 2012 Jun 1;71(11):939-46. doi: 10.1016/j.biopsych.2011.12.010. Epub 2012 Jan 31.
3
Induction of prolonged mania during ketamine therapy for reflex sympathetic dystrophy.氯胺酮治疗反射性交感神经营养不良期间诱发的持续性躁狂。
Biol Psychiatry. 2011 Aug 15;70(4):e13-4. doi: 10.1016/j.biopsych.2011.02.030. Epub 2011 May 6.
4
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.一项关于 N-甲基-D-天冬氨酸拮抗剂治疗难治性双相抑郁的随机附加试验。
Arch Gen Psychiatry. 2010 Aug;67(8):793-802. doi: 10.1001/archgenpsychiatry.2010.90.
5
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.在治疗抵抗性重度抑郁症患者中，单次输注 N-甲基-D-天冬氨酸拮抗剂后，自杀意念迅速缓解。
J Clin Psychiatry. 2010 Dec;71(12):1605-11. doi: 10.4088/JCP.09m05327blu. Epub 2010 Jul 13.
6
The neurobiology of the switch process in bipolar disorder: a review.双相障碍转换过程的神经生物学：综述。
J Clin Psychiatry. 2010 Nov;71(11):1488-501. doi: 10.4088/JCP.09r05259gre. Epub 2010 May 4.
7
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.国际双相情感障碍协会（ISBD）关于双相情感障碍病程和转归命名的特别工作组报告。
Bipolar Disord. 2009 Aug;11(5):453-73. doi: 10.1111/j.1399-5618.2009.00726.x.
8
The use of antidepressants in bipolar disorder.抗抑郁药在双相情感障碍中的应用。
J Clin Psychiatry. 2008 Aug;69(8):1307-18. doi: 10.4088/jcp.v69n0816.
9
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.伴有躁狂症状的双相抑郁患者辅助使用抗抑郁药与症状恢复情况：来自双相情感障碍系统治疗强化项目（STEP-BD）的研究结果
Am J Psychiatry. 2007 Sep;164(9):1348-55. doi: 10.1176/appi.ajp.2007.05122032.
10
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.一项关于N-甲基-D-天冬氨酸拮抗剂治疗难治性重度抑郁症的随机试验。
Arch Gen Psychiatry. 2006 Aug;63(8):856-64. doi: 10.1001/archpsyc.63.8.856.
Zotero 插件